Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2021

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Value of Derivative Instruments Included in Balance Sheets

The fair values of the Company's derivative financial instruments included in the condensed consolidated balance sheets are as follows:

(In thousands)	Balance Sheet  Location	September 30, 2021		December 31, 2020
Derivatives designated as hedging instruments:
Liabilities:
Interest rate swap contracts	Accrued liabilities	$	575	$	2,403
Derivatives not designated as hedging instruments:
Assets:
Foreign currency derivatives	Prepaid expenses and other current assets	$	190	$	300
Foreign currency derivatives	Other assets	110		367
Liabilities:
Foreign currency derivatives	Accrued liabilities	$	1,335	$	1,084
Foreign currency derivatives	Other liabilities	2,157		2,431

Schedule of Gains and Losses Related to Derivative Instruments

The amounts of gains and losses related to the Company's derivative financial instruments designated as hedging instruments are as follows:

(In thousands)	Gain or (Loss) on Derivatives  Recognized in OCI				Location of Gain or (Loss) in Earnings	Gain or (Loss) Reclassified  from Accumulated OCI  into Earnings
	Three Months Ended September 30,					Three Months Ended September 30,
	2021		2020			2021		2020
Derivatives in cash flow hedging relationships:
Interest rate swap contracts	$	(10)	$	9	Interest expense	$	630	$	606

(In thousands)	Gain or (Loss) on Derivatives  Recognized in OCI				Location of Gain or (Loss) in Earnings	Gain or (Loss) Reclassified  from Accumulated OCI  into Earnings
	Nine Months Ended September 30,					Nine Months Ended September 30,
	2021		2020			2021		2020
Derivatives in cash flow hedging relationships:
Interest rate swap contracts	$	(27)	$	(2,401)	Interest expense	$	1,855	$	1,360

Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location

The amounts of gains and losses related to the Company's derivative financial instruments not designated as hedging instruments are as follows:

(In thousands)	Location of Gain or (Loss) Recognized in Earnings on Derivatives	Amount of Gain or (Loss) Recognized in Earnings on Derivatives
		Three Months Ended September 30,				Nine Months Ended September 30,
		2021		2020		2021		2020
Foreign currency derivatives	Miscellaneous, net	$	(1,072)	$	(1,300)	$	(1,167)	$	(2,018)